Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion type Assertion NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_head.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion description "[We examined the pre-treatment tumour biopsies (n=40) obtained from patients with rectal adenocarcinoma (clinical International Union Against Cancer stage ll/III) who were scheduled to receive neoadjuvant 5-fluorouracil-based chemoradiotherapy for EGFR, VEGF and HIF-1 expression by quantitative real-time polymerase chain reaction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_provenance.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion evidence source_evidence_literature NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_provenance.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion SIO_000772 20117921 NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_provenance.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion wasDerivedFrom befree-20140225 NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_provenance.
- NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_assertion wasGeneratedBy ECO_0000203 NP660111.RAevwbLx-woIMUZ4QU2fWlVIbKyz9nlF-dV23KnMf28MM130_provenance.